Synthomer sees FY25 EBITDA below forecasts as sales miss estimates
Specialty chemicals firm Synthomer expects fiscal 2025 EBITDA of £135-138 million, modestly under analyst forecasts, and forecasts full-year sales of roughly £1.74 billion versus consensus of £1.82 billion. The company cited margin improvements driven by a strategic tilt toward higher-margin specialty products and cost reductions, while divisional …